We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aggressiveness of Care at the End of Life in Cancer Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00980122
First Posted: September 18, 2009
Last Update Posted: April 8, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National University Hospital, Singapore
  Purpose

Cancer is the commonest cause of death in Singapore, and many cancer deaths occur in hospital.

Management of cancer patients is getting more complex with constant development of new drugs, interventional procedures and supportive measures. Despite this, the majority of advanced cancer patients will die from their disease or related complications.

There is a lack of data on the utilisation of health resources in advanced cancer patients in this country. In this study the investigators ask themselves how aggressive care was in the last 3 months of the patient's life. The investigators will be collecting data on specific cancer treatments, interventional procedures, and supportive measures.


Condition
Advanced Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Aggressiveness of Care at the End of Life in Cancer Patients

Further study details as provided by National University Hospital, Singapore:

Primary Outcome Measures:
  • To describe the trends in the aggressiveness of care for advanced cancer patients near the end of life.

Estimated Enrollment: 250
Study Start Date: March 2008
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All advanced cancer patients who passed away in the National University Hospital during a defined 1 year period, will have a retrospective review of paper and electronic records.

Study subjects are identified from the weekly mortality lists that are sent to the Department of Haemtology Oncology. We aim to include 250 patients in this retrospective study.

Criteria

Inclusion Criteria:

  • Advanced cancer patients who passed away as an inpatient in NUH, under the department of Haematology Oncology.

Exclusion Criteria:

  • Patients with haematologic malignancies.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00980122


Locations
Singapore
National University Hospital
Singapore, Singapore, 119074
Sponsors and Collaborators
National University Hospital, Singapore
  More Information

Publications:
Responsible Party: Alvin Wong, National University Hospital, Singapore
ClinicalTrials.gov Identifier: NCT00980122     History of Changes
Other Study ID Numbers: MC05/30/07
First Submitted: September 16, 2009
First Posted: September 18, 2009
Last Update Posted: April 8, 2010
Last Verified: April 2010

Keywords provided by National University Hospital, Singapore:
Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.

Additional relevant MeSH terms:
Aggression
Behavioral Symptoms